150 related articles for article (PubMed ID: 17511723)
1. Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
Fukagai T; Maruyama K; Nagata M; Morita M; Naoe M; Yoshida H
Int J Urol; 2007 May; 14(5):412-5. PubMed ID: 17511723
[TBL] [Abstract][Full Text] [Related]
2. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
Fawzy A; Fontenot C; Guthrie R; Baudier MM
Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
[TBL] [Abstract][Full Text] [Related]
3. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns in screening and management of prostate cancer in elderly men.
Konety BR; Sharp VJ; Verma M; Williams RD;
Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
7. [Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina General, Sociedad Española de Medicina de Familia y Comunitaria, Asociación Española de Urología].
Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro A; Martín JA; Brenes Bermúdez FJ; Naval Pulido E; Molero JM; Pérez Morales D; ; ; ;
Actas Urol Esp; 2010 Jan; 34(1):24-34. PubMed ID: 20223130
[TBL] [Abstract][Full Text] [Related]
8. [General practitioners' approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany].
Coeurdacier P; Staerman F; Thoquenne G; Cipolla B; Guillé F; Lobel B
Prog Urol; 1996 Feb; 6(1):52-9. PubMed ID: 8624528
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic and therapeutic management of the benign prostatic hyperplasia by the general practitioners in the Maine-et-Loire].
Bigot P; Vannier F; Orsat M; Lebdai S; Huez JF; Fanello S; Azzouzi AR
Prog Urol; 2010 Jan; 20(1):65-70. PubMed ID: 20123530
[TBL] [Abstract][Full Text] [Related]
10. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
[TBL] [Abstract][Full Text] [Related]
11. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
Kranjcević K; Marković BB
Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
[TBL] [Abstract][Full Text] [Related]
12. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients].
Costa P; Ben Naoum K; Boukaram M; Wagner L; Louis JF
Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749
[TBL] [Abstract][Full Text] [Related]
13. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
[TBL] [Abstract][Full Text] [Related]
14. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
Paick JS; Kim SW; Ku JH
Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
[TBL] [Abstract][Full Text] [Related]
15. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
Barry MJ; Fowler FJ; Bin L; Oesterling JE
J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
[TBL] [Abstract][Full Text] [Related]
16. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
Fourcade RO; Théret N; Taïeb C;
BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
[TBL] [Abstract][Full Text] [Related]
17. Management of symptomatic BPH in Italy: who is treated and how?
Tubaro A; Montanari E
Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
[TBL] [Abstract][Full Text] [Related]
18. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R
Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709
[TBL] [Abstract][Full Text] [Related]
19. Attitudes and practices of primary care physicians for prostate cancer screening.
Hoffman RM; Papenfuss MR; Buller DB; Moon TE
Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
